Skip to main content

Table 1 The characteristic features of patients

From: A new method for predicting the microvascular invasion status of hepatocellular carcinoma through neural network analysis

 

MVI negative (N = 1462)

MVI positive (N = 235)

p

Sex (male, ratio)

1152 (78.80%)

200 (85.11%)

0.026

Age (years)

52.09 ± 13.43

49.15 ± 11.99

0.002

HGB (g/L)

139.16 ± 22.30

140.53 ± 21.68

0.210

WBC (× 109 /L)

6.48 ± 3.01

6.20 ± 2.91

0.742

PLT (× 109 /L)

139.65 ± 78.25

139.78 ± 76.10

0.981

NEU (%)

59.08 ± 18.66

63.30 ± 13.62

0.001

CHB (positive, ratio)

1102 (75.38%)

186 (79.15%)

0.209

Serum AFP (≥ 400 ng/mL, ratio)

500 (34.20%)

135 (57.45%)

< 0.001

TB (µmol/L)

18.88 ± 6.10

17.86 ± 5.06

0.588

AST (median IU/L)

45

47

0.231

ALT (median IU/L)

37

39

0.373

ALB (g/L)

41.07 ± 6.23

40.53 ± 5.40

0.215

PT (s)

12.00 ± 1.35

11.94 ± 1.45

0.588

Tumor type (single, ratio)

1261(86.25%)

184(78.30%)

0.001

Diameter (maximal tumor)

5.39 ± 3.14

7.01 ± 3.01

< 0.001

  1. HGB:Hemoglobin; WBC: Withe Blood Cell; PLT:Platelet; NEU: Percentage of Neutrophils; CHB: Chronic Hepatic B Virus; AFP:É‘-fetoprotein; TB: Total Bilirubin; AST:Aspartate aminotransferase; ALT:Alanine aminotransferase; ALB: Albumin; PT: Prothrombin Time